131 related articles for article (PubMed ID: 30079122)
1. Microfluidic on-chip immunohistochemistry directly from a paraffin-embedded section.
Cho CH; Kwon S; Kim S; Hong Y; Kim P; Lee ES; Park JK
Biomicrofluidics; 2018 Jul; 12(4):044110. PubMed ID: 30079122
[TBL] [Abstract][Full Text] [Related]
2. Microfluidic-based immunohistochemistry for breast cancer diagnosis: a comparative clinical study.
Aimi F; Procopio MG; Alvarez Flores MT; Brouland JP; Piazzon N; Brajkovic S; Dupouy DG; Gijs M; de Leval L
Virchows Arch; 2019 Sep; 475(3):313-323. PubMed ID: 31267199
[TBL] [Abstract][Full Text] [Related]
3. Single-day HER2neu amplification assessment using chip-based digital PCR in formalin-fixed paraffin-embedded breast carcinoma tissue.
Shah PS; Murarka S; Joshi A; Mehta B; Parmar V; Shah N; Patel K; Sands J
Breast Cancer (Dove Med Press); 2018; 10():121-129. PubMed ID: 30087576
[TBL] [Abstract][Full Text] [Related]
4. Breast cancer diagnostics using microfluidic multiplexed immunohistochemistry.
Kim MS; Kwon S; Park JK
Methods Mol Biol; 2013; 949():349-64. PubMed ID: 23329453
[TBL] [Abstract][Full Text] [Related]
5. Pipetting-driven microfluidic immunohistochemistry to facilitate enhanced immunoreaction and effective use of antibodies.
Kim S; Kwon S; Cho CH; Park JK
Lab Chip; 2017 Feb; 17(4):702-709. PubMed ID: 28145545
[TBL] [Abstract][Full Text] [Related]
6. Breast cancer diagnosis using a microfluidic multiplexed immunohistochemistry platform.
Kim MS; Kim T; Kong SY; Kwon S; Bae CY; Choi J; Kim CH; Lee ES; Park JK
PLoS One; 2010 May; 5(5):e10441. PubMed ID: 20454672
[TBL] [Abstract][Full Text] [Related]
7. Comparison of central laboratory assessments of ER, PR, HER2, and Ki67 by IHC/FISH and the corresponding mRNAs (ESR1, PGR, ERBB2, and MKi67) by RT-qPCR on an automated, broadly deployed diagnostic platform.
Wu NC; Wong W; Ho KE; Chu VC; Rizo A; Davenport S; Kelly D; Makar R; Jassem J; Duchnowska R; Biernat W; Radecka B; Fujita T; Klein JL; Stonecypher M; Ohta S; Juhl H; Weidler JM; Bates M; Press MF
Breast Cancer Res Treat; 2018 Nov; 172(2):327-338. PubMed ID: 30120700
[TBL] [Abstract][Full Text] [Related]
8. A fluorescence in situ hybridization (FISH) microfluidic platform for detection of HER2 amplification in cancer cells.
Kao KJ; Tai CH; Chang WH; Yeh TS; Chen TC; Lee GB
Biosens Bioelectron; 2015 Jul; 69():272-9. PubMed ID: 25770459
[TBL] [Abstract][Full Text] [Related]
9. Human epidermal growth factor receptor 2 amplification detection by droplet digital polymerase chain reaction in formalin-fixed paraffin-embedded breast and gastric cancer samples.
Wang X; Wu Y; Song X; Sun C; Wu C; Feng H
J Cancer Res Ther; 2017; 13(4):730-734. PubMed ID: 28901323
[TBL] [Abstract][Full Text] [Related]
10. Droplet digital polymerase chain reaction detection of HER2 amplification in formalin fixed paraffin embedded breast and gastric carcinoma samples.
Zhu Y; Lu D; Lira ME; Xu Q; Du Y; Xiong J; Mao M; Chung HC; Zheng G
Exp Mol Pathol; 2016 Apr; 100(2):287-93. PubMed ID: 26626802
[TBL] [Abstract][Full Text] [Related]
11. Droplet digital PCR measurement of HER2 copy number alteration in formalin-fixed paraffin-embedded breast carcinoma tissue.
Belgrader P; Tanner SC; Regan JF; Koehler R; Hindson BJ; Brown AS
Clin Chem; 2013 Jun; 59(6):991-4. PubMed ID: 23358413
[TBL] [Abstract][Full Text] [Related]
12. Quantitative RT-PCR assay of HER2 mRNA expression in formalin-fixed and paraffin-embedded breast cancer tissues.
Park S; Wang HY; Kim S; Ahn S; Lee D; Cho Y; Park KH; Jung D; Kim SI; Lee H
Int J Clin Exp Pathol; 2014; 7(10):6752-9. PubMed ID: 25400755
[TBL] [Abstract][Full Text] [Related]
13. Human epidermal growth factor receptor 2 testing in gastroesophageal cancer: correlation between immunohistochemistry and fluorescence in situ hybridization.
Tafe LJ; Janjigian YY; Zaidinski M; Hedvat CV; Hameed MR; Tang LH; Hicks JB; Shah MA; Barbashina V
Arch Pathol Lab Med; 2011 Nov; 135(11):1460-5. PubMed ID: 22032573
[TBL] [Abstract][Full Text] [Related]
14. HER2 gene and protein expression status of breast carcinoma can be reliably tested on a single slide.
Chenard MP; Wissler MP; Weingertner N; Mathelin C; Bellocq JP
Virchows Arch; 2015 Aug; 467(2):169-75. PubMed ID: 25985875
[TBL] [Abstract][Full Text] [Related]
15. A Microfluidic Immunostaining System Enables Quality Assured and Standardized Immunohistochemical Biomarker Analysis.
Kwon S; Cho CH; Kwon Y; Lee ES; Park JK
Sci Rep; 2017 Apr; 7():45968. PubMed ID: 28378835
[TBL] [Abstract][Full Text] [Related]
16. Tissue lithography: Microscale dewaxing to enable retrospective studies on formalin-fixed paraffin-embedded (FFPE) tissue sections.
Cors JF; Kashyap A; Fomitcheva Khartchenko A; Schraml P; Kaigala GV
PLoS One; 2017; 12(5):e0176691. PubMed ID: 28493979
[TBL] [Abstract][Full Text] [Related]
17. Human epidermal growth factor receptor 2 expression in breast cancer: correlation with clinical pathological features.
Ning SF; Li JL; Luo CP; Wei CH; Lu YK; Liu HZ; Wei WE; Zhang LT
Int J Clin Exp Pathol; 2014; 7(12):8740-7. PubMed ID: 25674240
[TBL] [Abstract][Full Text] [Related]
18. Her2/neu analysis in formalin-fixed, paraffin-embedded breast carcinomas: comparison of immunohistochemistry and multiparameter DNA flow cytometry.
Leers MP; Hoop JG; Nap M
Anticancer Res; 2003; 23(2A):999-1006. PubMed ID: 12820338
[TBL] [Abstract][Full Text] [Related]
19. Comparison of automated and manual determination of HER2 status in breast cancer for diagnostic use: a comparative methodological study using the Ventana BenchMark automated staining system and manual tests.
Bánkfalvi A; Boecker W; Reiner A
Int J Oncol; 2004 Oct; 25(4):929-35. PubMed ID: 15375542
[TBL] [Abstract][Full Text] [Related]
20. Gene protein detection platform--a comparison of a new human epidermal growth factor receptor 2 assay with conventional immunohistochemistry and fluorescence in situ hybridization platforms.
Stålhammar G; Farrajota P; Olsson A; Silva C; Hartman J; Elmberger G
Ann Diagn Pathol; 2015 Aug; 19(4):203-10. PubMed ID: 25921313
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
